Autolus Therapeutics announces publication of obe-cel (AUTO1) Phase 1 ALLCAR19 data in adults with relapsed/ refractory B-ALL in Journal of Clinical Oncology

NEXT STORY
Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer
PREV STORY
MediciNova Announces MN-001 (tipelukast) Abstract regarding Lipid Metabolism in NASH/NAFLD Accepted for Presentation at The Liver Meeting® 2021, the Annual Meeting of the American Association for the Study of Liver Diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Strongbridge Biopharma plc Announces Data Presentation at the Society for Endocrinology BES 2015 Conference

DUBLIN, Ireland and TREVOSE, Pa., Nov. 3, 2015 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc ...

author_avatar
NASDAQ Market News

Akari Therapeutics Announces Successful Scientific Advice Meeting with the European Medicines Agency (EMA) Establishing a Clear Path in Both U.S. and Europe for a Pivotal Phase III Study of Nomacopan for Treatment of Bullous Pemphigoid

author_avatar
NASDAQ Market News

EU Boosts Evaxion’s Artificial Intelligence Vaccine Research

author_avatar
NASDAQ Market News